The bill preserves state authority to protect health and increase ingredient transparency while creating regulatory fragmentation that raises compliance costs for manufacturers and risks higher prices, reduced availability, and inconsistent consumer information.
Consumers and state governments can keep or adopt stronger reporting and disclosure rules for cosmetics, giving consumers more ingredient information and improving transparency.
States and local governments retain authority to ban or limit cosmetic ingredients, allowing communities to address local health and safety concerns.
Manufacturers gain clearer federal preemption boundaries so they better understand which state rules are not preempted, reducing some legal uncertainty.
Consumers may face higher product prices or reduced product availability if manufacturers reformulate or withdraw products to meet differing state standards.
Cosmetic manufacturers may confront a patchwork of differing state bans, limits, and reporting rules, increasing compliance costs and business complexity.
Consumers may be confused by inconsistent disclosure requirements across states, reducing clarity and making it harder to compare product information.
Based on analysis of 2 sections of legislative text.
Clarifies that States and localities may continue to restrict cosmetic ingredients and require disclosure or reporting despite the 2022 federal law, except where that law expressly preempts them.
Clarifies federal preemption rules for cosmetics regulation so that States and their political subdivisions may continue to prohibit or limit cosmetic ingredients, keep existing state reporting requirements that were in effect when the 2022 law passed, and adopt or maintain requirements that give greater transparency, disclosure, or protection than the 2022 federal law. It makes clear the 2022 law does not preempt State actions except where the federal statute expressly does so.
Introduced July 16, 2025 by Janice D. Schakowsky · Last progress July 16, 2025